156 related articles for article (PubMed ID: 19424641)
21. Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.
Chojnacki K; Wińska P; Skierka K; Wielechowska M; Bretner M
Bioorg Chem; 2017 Jun; 72():1-10. PubMed ID: 28340404
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines.
Schneider CC; Götz C; Hessenauer A; Günther J; Kartarius S; Montenarh M
Mol Cell Biochem; 2011 Oct; 356(1-2):177-84. PubMed ID: 21750987
[TBL] [Abstract][Full Text] [Related]
23. Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription.
Tapia JC; Torres VA; Rodriguez DA; Leyton L; Quest AF
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15079-84. PubMed ID: 17005722
[TBL] [Abstract][Full Text] [Related]
24. Hemoglobin neurotoxicity is attenuated by inhibitors of the protein kinase CK2 independent of heme oxygenase activity.
Chen-Roetling J; Li Z; Regan RF
Curr Neurovasc Res; 2008 Aug; 5(3):193-8. PubMed ID: 18691077
[TBL] [Abstract][Full Text] [Related]
25. Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells.
Ahmad KA; Wang G; Ahmed K
Mol Cancer Res; 2006 May; 4(5):331-8. PubMed ID: 16687488
[TBL] [Abstract][Full Text] [Related]
26. TF--a novel cell-permeable and selective inhibitor of human protein kinase CK2 induces apoptosis in the prostate cancer cell line LNCaP.
Götz C; Gratz A; Kucklaender U; Jose J
Biochim Biophys Acta; 2012 Jul; 1820(7):970-7. PubMed ID: 22387500
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
Najda-Bernatowicz A; Łebska M; Orzeszko A; Kopańska K; Krzywińska E; Muszyńska G; Bretner M
Bioorg Med Chem; 2009 Feb; 17(4):1573-8. PubMed ID: 19168362
[TBL] [Abstract][Full Text] [Related]
28. Treatment of cultured human astrocytes and vascular endothelial cells with protein kinase CK2 inhibitors induces early changes in cell shape and cytoskeleton.
Kramerov AA; Golub AG; Bdzhola VG; Yarmoluk SM; Ahmed K; Bretner M; Ljubimov AV
Mol Cell Biochem; 2011 Mar; 349(1-2):125-37. PubMed ID: 21125314
[TBL] [Abstract][Full Text] [Related]
29. Effect of Simultaneous Inhibition of Protein Kinase CK2 and Thymidylate Synthase in Leukemia and Breast Cancer Cells.
Wińska P; Skierka K; Łukowska-Chojnacka E; Koronkiewicz M; Cieśla J; Bretner M
Anticancer Res; 2018 Aug; 38(8):4617-4627. PubMed ID: 30061228
[TBL] [Abstract][Full Text] [Related]
30. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
[TBL] [Abstract][Full Text] [Related]
31. CK2 inhibition induces apoptosis via the ER stress response.
Hessenauer A; Schneider CC; Götz C; Montenarh M
Cell Signal; 2011 Jan; 23(1):145-51. PubMed ID: 20807566
[TBL] [Abstract][Full Text] [Related]
32. Characterization of ATM and DNA-PK wild-type and mutant cell lines upon DSB induction in the presence and absence of CK2 inhibitors.
Olsen BB; Fritz G; Issinger OG
Int J Oncol; 2012 Feb; 40(2):592-8. PubMed ID: 21993375
[TBL] [Abstract][Full Text] [Related]
33. Casein kinase-II inhibition promotes retinal ganglion cell survival and axonal regeneration.
Cen LP; Liu YF; Ng TK; Luo JM; van Rooijen N; Zhang M; Pang CP; Cui Q
Exp Eye Res; 2018 Dec; 177():153-159. PubMed ID: 30118655
[TBL] [Abstract][Full Text] [Related]
34. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
[TBL] [Abstract][Full Text] [Related]
35. Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.
Trembley JH; Unger GM; Korman VL; Tobolt DK; Kazimierczuk Z; Pinna LA; Kren BT; Ahmed K
Cancer Lett; 2012 Feb; 315(1):48-58. PubMed ID: 22050909
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.
Zhao T; Jia H; Li L; Zhang G; Zhao M; Cheng Q; Zheng J; Li D
Oncol Rep; 2013 Jul; 30(1):377-84. PubMed ID: 23595577
[TBL] [Abstract][Full Text] [Related]
37. Halogenated imidazole derivatives block RNA polymerase II elongation along mitogen inducible genes.
Mikula M; Hanusek K; Paziewska A; Dzwonek A; Rubel T; Bomsztyk K; Ostrowski J
BMC Mol Biol; 2010 Jan; 11():4. PubMed ID: 20078881
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and proapoptotic properties of new casein kinase II inhibitors.
Koronkiewicz M; Zukowska M; Chilmonczyk Z; Orzeszko A; Kazimierczuk Z
Acta Pol Pharm; 2010; 67(6):635-41. PubMed ID: 21229880
[TBL] [Abstract][Full Text] [Related]
39. Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells.
Wang G; Ahmad KA; Harris NH; Ahmed K
Mol Cell Biochem; 2008 Sep; 316(1-2):91-7. PubMed ID: 18574673
[TBL] [Abstract][Full Text] [Related]
40. Involvement of reactive oxygen species in apoptosis induced by pharmacological inhibition of protein kinase CK2.
Hanif IM; Ahmad KA; Ahmed K; Pervaiz S
Ann N Y Acad Sci; 2009 Aug; 1171():591-9. PubMed ID: 19723109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
